Nalaganje...
Sacubitril–valsartan in heart failure and multimorbidity patients
AIMS: The poor control of symptoms in patients with advanced heart failure with reduced ejection function (HFrEF) can limit the functionality of patients. Sacubitril–valsartan, compared with enalapril, has been shown to reduce mortality and hospitalization, and nowadays, there is still little eviden...
Shranjeno v:
| izdano v: | ESC Heart Fail |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6165940/ https://ncbi.nlm.nih.gov/pubmed/30039930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12338 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|